510(k) Report

510(k) · Cleared

Cleared

Redsense

K071013510(k) TraditionalCleared Oct 18, 2007191-day reviewClass II21 CFR 876.5820

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Redsense Medical AB · ODX Autonomous Extracorporeal Blood Leak Detector/Alarm

Cleared on Oct 18, 2007 as substantially equivalent to K972314 (Diametrics Medical, Ltd., 1997) and 1 other predicate after a 191-day review. Its family tree reaches back 1 generation to 1989. 3 later devices descend from it.

Decided
Oct 18, 2007
Review
191 days
Class
Class II
Product code
ODX
Recalls
None
Predicates
2

Its longest line of descent runs back 1 generation to K890824 (1989). 2 ancestors in all. 3 later devices descend from it, 3 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 1997: 1 other ancestor2011: 1 descendant cleared2013: 1 descendant cleared2010: 1 descendant clearedK890824 · Fresenius 2008 Touch Panel Control Dialysis System · Fresenius USA, Inc. · 19891990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 3 descendants K890824 · Fresenius 2008 Touch Panel Control Dialysis System · Fresenius USA, Inc. · 19890
  1. Root · 1 generation backK890824 Fresenius 2008 Touch Panel Control Dialysis SystemFresenius USA, Inc. · 1989
  2. This deviceK071013 RedsenseRedsense Medical AB · 2007
  3. Descendant · cites it directly · 2 of its ownK092955 Redsense-Home UseRedsense Medical AB · 2010
  4. Descendant · cites it directly · 1 of its ownK103242 Redsense-Alarm Unit and SensorRedsense Medical AB · 2011
  5. Descendant · cites it directly · 0 of its ownK130554 Redsense Alarm SystemRedsense Medical AB · 2013

Most influential descendants

Showing 3 of 3 · See all
  • K092955Redsense-Home UseRedsense Medical AB · 2010 · cites it directly2descendants
  • K103242Redsense-Alarm Unit and SensorRedsense Medical AB · 2011 · cites it directly1descendant
  • K130554Redsense Alarm SystemRedsense Medical AB · 2013 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K890824Fresenius 2008 Touch Panel Control Dialysis SystemFresenius USA, Inc.1989—
0 (this device)K071013RedsenseRedsense Medical AB2007—
+1K092955Redsense-Home UseRedsense Medical AB2010—
+1K103242Redsense-Alarm Unit and SensorRedsense Medical AB2011—
+1K130554Redsense Alarm SystemRedsense Medical AB2013—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
201110
201310
FIG. 1 — Lineage of K071013, 1989–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in ODX? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K972314Paratrend 7 Neotrend Multiparameter/Sensor with Paratrend 7 Multiparameter Senior and…
Summary page 1
…Fridley, MN 55432 Submission Date: Device Name and Classification: Redsense, Class II, 876.5540, product code not known Equivalent Device Identification: Neotrend (K972314) and Fresenius 2008 Touch panel control Dialysis system (K890824) Device Description: Redsense is a system for monitoring the ve…
Diametrics Medical, Ltd.1997—
*K890824Fresenius 2008 Touch Panel Control Dialysis System
Summary page 1
…ation: Redsense, Class II, 876.5540, product code not known Equivalent Device Identification: Neotrend (K972314) and Fresenius 2008 Touch panel control Dialysis system (K890824) Device Description: Redsense is a system for monitoring the vein or arterial needle during hemodialysis. Redsense consists of a…
Fresenius USA, Inc.1989—

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K092955Redsense-Home UseRedsense Medical AB20102
K103242Redsense-Alarm Unit and SensorRedsense Medical AB20111
K130554Redsense Alarm SystemRedsense Medical AB20130

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • None of the 2 ancestors has a recall.
  • Of its descendants, K092955 (Redsense Medical AB, 2010) has gone furthest, with 2 descendants of its own.

How does its category compare?

All ODX devices

ODX Autonomous Extracorporeal Blood Leak Detector/Alarm: FDA decisions, review times, recalls and adverse event reports over 20 years. 2007, this device’s year, is highlighted.

FDA decisions per year · ODX

1in 2013

2007: 12010: 12011: 12013: 1
2007high 1 (2007) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · ODX

Too few ODX 510(k)s in any year since 2007 to give a median.

Recalls per year · ODX

1in 2011

2011: 1
2007high 1 (2011) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · ODX

1in 2025

2010: 22011: 12012: 12013: 22017: 12018: 12020: 22025: 1
2007high 2 (2010) · low 0 (2007)2025

MAUDE reports naming product code ODX, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20080—00
20090—00
20101—02
20111—11
20120—01
20131—02
20140—00
20150—00
20160—00
20170—01
20180—01
20190—00
20200—02
20210—00
20220—00
20230—00
20240—00
20250—01
20260—0—

What is it indicated for?

The Redsense device is intended to monitor for potential blood loss from the hemodialysis access site in hemodialysis patients undergoing continuous hemodialysis treatment up to 5 hours in the clinical setting. The device includes a blood sensor incorporated into an adhesive sensor patch. The sensor monitors potential blood leakage from the venous needle puncture site via an infrared light and will alarm if blood leakage is detected via absorption onto the device's sensor patch.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K071013: Redsense.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K071013

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026